https://doi.org/10.51271/JCHOR-0032

Citation : Ünal A, Göktepe Ö, Çetinkaya M, Baran Y. Determination of the therapeutic effects of apigenin on chronic myeloid leukemia stem cells; a mechanistic approach. J Curr Hematol Oncol Res. 2024;2(2):24-27.

https://doi.org/10.51271/JCHOR-0033

Citation : Eryıldız Yücel S, Kuku İ, Kaya E, Erkurt MA, Berber İ. Retrospective evaluation of indications for therapeutic plasmapheresis procedures applied in our center. J Curr Hematol Oncol Res. 2024;2(2):28-32.

https://doi.org/10.51271/JCHOR-0034

Citation : Kuzucular E, Doran F. Evaluation of the relationship between immunohistochemical markers and the prognosis of patients with hepatocellular carcinoma. J Curr Hematol Oncol Res. 2024;2(2):33-40.

https://doi.org/10.51271/JCHOR-0035

Citation : Keklik M, Topal L, Çelik S, Kaynar L. Does early granulocyte colony-stimulating factor administration in autologous peripheral blood stem cell transplantation shorten the duration of hospitalization in patients with multiple myeloma?.J Curr Hematol Oncol Res. 2024;2(2):41-46.

https://doi.org/10.51271/JCHOR-0036

Citation : Hacıömeroğlu A, Yalçın S. Superior vena cava syndrome. J Curr Hematol Oncol Res. 2024;2(2): 47-50.

https://doi.org/10.51271/JCHOR-0037

Citation : Çayıröz K, Tokatlı M, Narlı P, et al. A rare blood transfusion complication: Bacillus thermoamylovorans bacteremia and diffuse pustular rash. J Curr Hematol Oncol Res. 2024; 2(2):51-53.